Skip to main content
Year archive

ArcticZymes Technologies — 2018 filings

All 70 regulatory filings released by ArcticZymes Technologies (AZT) in 2018, sourced directly from the official regulator.

70 Filings
2018 Period
2018 filings (70)
Filing Released Lang
ArcticZymes and Vectron Biosolutions sign license agreement on recombinant enzyme expression technology
Regulatory Filings
2018-12-20 English
ArcticZymes and Vectron Biosolutions sign license agreement on recombinant enzyme expression technology
Regulatory Filings
2018-12-20 English
ArcticZymes signs new supply agreement for enzyme, Cod UNG
Regulatory Filings
2018-12-13 English
ArcticZymes signs new supply agreement for enzyme, Cod UNG
Regulatory Filings
2018-12-13 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2018-11-14 English
Biotec renews clinical trial agreement with Memorial Sloan Kettering Cancer Center
Regulatory Filings
2018-11-13 English
Biotec renews clinical trial agreement with Memorial Sloan Kettering Cancer Center
Legal Proceedings Report
2018-11-13 English
Biotec Pharmacon will present at Biotech & Money, Investival Showcase
Investor Presentation
2018-11-13 English
Biotec Pharmacon will present at Biotech & Money, Investival Showcase
Report Publication Announcement
2018-11-13 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2018-10-23 English
Financial calendar
Report Publication Announcement
2018-10-22 English
Biotec Pharmacon: Results for Q3 2018
Earnings Release Q3 2018
2018-10-18 English
Biotec Pharmacon: Q3 2018 Presentation
Investor Presentation
2018-10-18 English
Biotec Pharmacon: Q3 2018 Presentation
Report Publication Announcement
2018-10-18 English
Biotec Pharmacon ASA: Invitation to presentation of Q3 2018 results
Report Publication Announcement
2018-10-11 English
ArcticZymes AS secures first supply agreement for utility of Salt Active Nuclease in Gene Therapy
Regulatory Filings
2018-09-30 English
ArcticZymes AS secures first supply agreement for utility of Salt Active Nuclease in Gene Therapy
Regulatory Filings
2018-09-30 English
Biotec Pharmacon changes management in the wound care area
Board/Management Information
2018-09-20 English
Biotec Pharmacon changes management in the wound care area
Board/Management Information
2018-09-20 English
Biotec Pharmacon ASA will present at LSX Nordic Conference
Investor Presentation
2018-08-30 English
Biotec Pharmacon ASA will present at LSX Nordic Conference
Report Publication Announcement
2018-08-30 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2018-08-17 English
Biotec Pharmacon: Results for Q2 2018
Report Publication Announcement Q2 2018
2018-08-16 English
Biotec Pharmacon: Q2 2018 Presentation
Investor Presentation
2018-08-16 English
Biotec Pharmacon: Q2 2018 Presentation
Report Publication Announcement
2018-08-16 English
Biotec Pharmacon ASA: Invitation to presentation of Q2 2018 results
Report Publication Announcement
2018-08-08 English
Biotec Pharmacon ASA: Invitation to presentation of Q2 2018 results
Report Publication Announcement
2018-08-08 English
BIOTEC - REGISTERED SHARE CAPITAL INCREASE
Share Issue/Capital Change
2018-06-21 English
BIOTEC - REGISTERED SHARE CAPITAL INCREASE
Capital/Financing Update
2018-06-21 English
ArcticZymes launches its first Proteinase enzyme
Regulatory Filings
2018-06-20 English
ArcticZymes launches its first Proteinase enzyme
Regulatory Filings
2018-06-20 English
BIOTEC - SUCCESSFULLY COMPLETED PRIVATE PLACEMENT
Capital/Financing Update
2018-06-14 English
BIOTEC - SUCCESSFULLY COMPLETED PRIVATE PLACEMENT
Share Issue/Capital Change
2018-06-14 English
BIOTEC - CONTEMPLATED PRIVATE PLACEMENT
Share Issue/Capital Change
2018-06-14 English
BIOTEC - CONTEMPLATED PRIVATE PLACEMENT
Capital/Financing Update
2018-06-14 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2018-05-16 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2018-05-14 English
Correction category - Results from Neuroblastoma Phase II vaccine study indicate promising adjuvant (SBG®) effect
Earnings Release Q2 2018
2018-05-14 English
Correction category - Results from Neuroblastoma Phase II vaccine study indicate promising adjuvant (SBG®) effect
Regulatory Filings
2018-05-14 English
Results from Neuroblastoma Phase II vaccine study indicate promising adjuvant (SBG®) effect
Earnings Release Q2 2018
2018-05-13 English
Results from Neuroblastoma Phase II vaccine study indicate promising adjuvant (SBG®) effect
Regulatory Filings
2018-05-13 English
Collaboration to investigate yeast beta-glucan growth opportunities within land animal feed
Regulatory Filings
2018-05-08 English
Collaboration to investigate yeast beta-glucan growth opportunities within land animal feed
Regulatory Filings
2018-05-08 English
Biotec Pharmacon - Minutes from Annual General Meeting
AGM Information
2018-05-07 English
Biotec Pharmacon - Minutes from Annual General Meeting
AGM Information
2018-05-07 English
Biotec Pharmacon ASA - Flagging av fullmakter
Proxy Solicitation & Information Statement
2018-05-04 Norwegian
Biotec Pharmacon: Results for Q1 2018
Earnings Release Q1 2018
2018-04-26 Norwegian
Biotec Pharmacon: Results for Q1 2018
Interim / Quarterly Report Q1 2018
2018-04-26 Norwegian
Biotec Pharmacon: Q1 2018 Presentation
Investor Presentation
2018-04-26 English
Biotec Pharmacon: Results for Q1 2018
Earnings Release Q1 2018
2018-04-26 English
Biotec Pharmacon: Q1 2018 Presentation
Report Publication Announcement
2018-04-26 English
Biotec Pharmacon ASA: Invitation to presentation of Q1 2018 results
Report Publication Announcement
2018-04-17 English
Biotec Pharmacon ASA: Invitation to presentation of Q1 2018 results
Report Publication Announcement
2018-04-17 English
Biotec Pharmacon ASA - Annual report 2017
Annual Report FY 2017
2018-04-13 Norwegian
Biotec Pharmacon ASA - Annual report 2017
Report Publication Announcement
2018-04-13 English
Biotec Pharmacon ASA - Notice of Annual General Meeting
AGM Information
2018-04-13 English
Biotec Pharmacon ASA - Notice of Annual General Meeting
AGM Information
2018-04-13 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2018-03-19 English
Financial calendar
Report Publication Announcement
2018-03-15 English
Strong Woulgan results from 300 patient study
Regulatory Filings
2018-03-01 English
Strong Woulgan results from 300 patient study
Regulatory Filings
2018-03-01 English
Styreleder fratrer ved 2018 generalforsamling
Board/Management Information
2018-02-01 Norwegian
Styreleder fratrer ved 2018 generalforsamling
Board/Management Information
2018-02-01 Norwegian
Biotec Pharmacon: Results for Q4 2017
Earnings Release Q4 2017
2018-02-01 Norwegian
Biotec Pharmacon: Results for Q4 2017
Interim / Quarterly Report Q4 2017
2018-02-01 Norwegian
Biotec Pharmacon: Q4 2017 Presentation
Investor Presentation
2018-02-01 English
Biotec Pharmacon: Results for Q4 2017
Report Publication Announcement Q4 2017
2018-02-01 English
Biotec Pharmacon: Q4 2017 Presentation
Report Publication Announcement
2018-02-01 English
Biotec Pharmacon ASA: Invitation to presentation of Q4 2017 results
Report Publication Announcement
2018-01-24 English
Biotec Pharmacon ASA: Invitation to presentation of Q4 2017 results
Report Publication Announcement
2018-01-24 English